MVIR:STO
Medivir AB
1,48 SEK
arrow_downward
-0,94%(-0,014) 1 d.
12. 10., 12:07:33 GMT+2 · SEK
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre MVIR…
Otvoriť
1,49 SEK
Vysoká
1,51 SEK
Nízka
1,46 SEK
Trh. kap.
926,27 mil.
Priem. obj.
1,45 mil.
Objem
596,00 tis.
Max. za 52 týž.
2,88 SEK
Min. za 52 týž.
0,34 SEK
Výnosy na akciu
-0,37 SEK
Akcie v obehu
624,18 mil.
Počet zamestnancov
6
Otvoriť
1,49 SEK
Vysoká
1,51 SEK
Nízka
1,46 SEK
Trh. kap.
926,27 mil.
Priem. obj.
1,45 mil.
Objem
596,00 tis.
Max. za 52 týž.
2,88 SEK
Min. za 52 týž.
0,34 SEK
Výnosy na akciu
-0,37 SEK
Akcie v obehu
624,18 mil.
Počet zamestnancov
6
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo Finance
·
pred 1 hodinou
Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus
Sahi
·
pred 42 minútami
Black Box Shows Interest In Nasdaq Listed Aeries Technology Reporting $70 Million FY26 Revenue
The Motley Fool
·
pred 7 minútami
Vanguard's S&P 500 Fund Has Raised Its Payout 71% Since 2016. Its Yield Has Nearly Halved.
Bloomberg.com
·
pred 11 hodinami
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
Profil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Informácie o subjekte Medivir AB